Candida auris in US Correctional Facilities

Emerg Infect Dis. 2024 Apr;30(13):S36-S40. doi: 10.3201/eid3013.230860.

Abstract

Candida auris is an emerging fungal pathogen that typically affects patients in healthcare settings. Data on C. auris cases in correctional facilities are limited but are needed to guide public health recommendations. We describe cases and challenges of providing care for 13 patients who were transferred to correctional facilities during January 2020-December 2022 after having a positive C. auris specimen. All patients had positive specimens identified while receiving inpatient care at healthcare facilities in geographic areas with high C. auris prevalence. Correctional facilities reported challenges managing patients and implementing prevention measures; those challenges varied by whether patients were housed in prison medical units or general population units. Although rarely reported, C. auris cases in persons who are incarcerated may occur, particularly in persons with known risk factors. Measures to manage cases and prevent C. auris spread in correctional facilities should address setting-specific challenges in healthcare and nonhealthcare correctional environments.

Keywords: Candida auris; United States; antimicrobial resistance; correctional facilities; correctional health; fungi; infection prevention and control; multidrug-resistant organism; prisons.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candida auris
  • Candida*
  • Candidiasis* / microbiology
  • Correctional Facilities
  • Humans

Substances

  • Antifungal Agents